NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Vaccines platforms and COVID-19: what you need to know

PDF) COVID‐19: Clinical status of vaccine development till date

Vaccine Adjuvant Discovery and Mechanistic Research

Vaccine - Wikipedia

Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for

World experts to gather for IVI symposium on hepatitis E – IVI

Frontiers Progress and Pitfalls in the Quest for Effective SARS

Intestinal helminth infection impairs oral and parenteral vaccine

PDF) Vaccine Strategies to Elicit Mucosal Immunity

Frontiers Factors Which Contribute to the Immunogenicity of Non